ZA985126B - Novel niddm regimen - Google Patents
Novel niddm regimenInfo
- Publication number
- ZA985126B ZA985126B ZA985126A ZA985126A ZA985126B ZA 985126 B ZA985126 B ZA 985126B ZA 985126 A ZA985126 A ZA 985126A ZA 985126 A ZA985126 A ZA 985126A ZA 985126 B ZA985126 B ZA 985126B
- Authority
- ZA
- South Africa
- Prior art keywords
- niddm
- regimen
- novel
- metformin
- repaglinide
- Prior art date
Links
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 abstract 2
- 229960003105 metformin Drugs 0.000 abstract 2
- FAEKWTJYAYMJKF-QHCPKHFHSA-N GlucoNorm Chemical compound C1=C(C(O)=O)C(OCC)=CC(CC(=O)N[C@@H](CC(C)C)C=2C(=CC=CC=2)N2CCCCC2)=C1 FAEKWTJYAYMJKF-QHCPKHFHSA-N 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 230000002641 glycemic effect Effects 0.000 abstract 1
- 229940126904 hypoglycaemic agent Drugs 0.000 abstract 1
- 229960002354 repaglinide Drugs 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK69497 | 1997-06-13 | ||
US6336897P | 1997-10-29 | 1997-10-29 | |
PCT/DK1998/000248 WO1998056378A1 (en) | 1997-06-13 | 1998-06-12 | Novel niddm regimen |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA985126B true ZA985126B (en) | 1998-12-14 |
Family
ID=26064473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA985126A ZA985126B (en) | 1997-06-13 | 1998-06-12 | Novel niddm regimen |
Country Status (13)
Country | Link |
---|---|
US (1) | US6677358B1 (ja) |
EP (2) | EP1011673B1 (ja) |
JP (2) | JP2002500677A (ja) |
AT (1) | ATE201139T1 (ja) |
AU (1) | AU7906898A (ja) |
DE (1) | DE69800806T2 (ja) |
DK (1) | DK1011673T3 (ja) |
ES (1) | ES2159184T3 (ja) |
GR (1) | GR3036078T3 (ja) |
HK (1) | HK1030872A1 (ja) |
PT (1) | PT1011673E (ja) |
WO (1) | WO1998056378A1 (ja) |
ZA (1) | ZA985126B (ja) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4175662B2 (ja) | 1996-01-08 | 2008-11-05 | インパルス ダイナミクス エヌ.ヴイ. | 電気的筋肉制御装置 |
US9289618B1 (en) | 1996-01-08 | 2016-03-22 | Impulse Dynamics Nv | Electrical muscle controller |
US9713723B2 (en) | 1996-01-11 | 2017-07-25 | Impulse Dynamics Nv | Signal delivery through the right ventricular septum |
US7006871B1 (en) | 1997-07-16 | 2006-02-28 | Metacure N.V. | Blood glucose level control |
US20040102486A1 (en) * | 1998-11-12 | 2004-05-27 | Smithkline Beecham Corporation | Novel method of treatment |
US20030153607A1 (en) * | 1998-11-12 | 2003-08-14 | Smithkline Beecham P.L.C. | Novel composition and use |
US20040081697A1 (en) * | 1998-11-12 | 2004-04-29 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
US6958324B2 (en) | 1998-12-02 | 2005-10-25 | Inotek Pharmaceuticals Corporation | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease |
US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
WO2006073671A1 (en) | 2004-12-09 | 2006-07-13 | Impulse Dynamics Nv | Protein activity modification |
AR028299A1 (es) * | 1999-09-17 | 2003-05-07 | Novartis Ag | Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes. |
US6878749B2 (en) | 1999-09-17 | 2005-04-12 | Novartis Ag | Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
US6559188B1 (en) | 1999-09-17 | 2003-05-06 | Novartis Ag | Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes |
US6586438B2 (en) * | 1999-11-03 | 2003-07-01 | Bristol-Myers Squibb Co. | Antidiabetic formulation and method |
WO2001047514A1 (en) | 1999-12-23 | 2001-07-05 | Novartis Ag | Use of hypoglycemic agent for treating impaired glucose metabolism |
AU2007201729B2 (en) * | 1999-12-23 | 2010-02-25 | Novartis Ag | Use of hypoglycemic agent for treating impaired glucose metabolism |
DE60024320T2 (de) | 1999-12-28 | 2006-08-10 | Ajinomoto Co., Inc. | Orale zusammensetzungen für diabetes |
WO2001052860A2 (en) * | 2000-01-24 | 2001-07-26 | Inotek Corporation | Method and composition for modulating an immune response |
EP2330092A3 (en) * | 2000-02-01 | 2012-07-25 | Stevia APS | Medicament comprising steviol or isosteviol for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
WO2001068136A1 (fr) * | 2000-03-17 | 2001-09-20 | Ajinomoto Co., Inc. | Medicaments permettant de traiter les complications du diabete et des neuropathies et utilisation de ces medicaments |
EP1738751B1 (en) | 2001-01-12 | 2011-05-11 | Sun Pharma Advanced Research Company Ltd | Spaced drug delivery system |
US7956041B2 (en) | 2002-04-26 | 2011-06-07 | Ajinomoto Co., Inc. | Prophylactic and therapeutic agent of diabetes mellitus |
EP1500403A4 (en) * | 2002-04-26 | 2008-09-17 | Ajinomoto Kk | MEANS FOR THE PREVENTION / TREATMENT OF DIABETES |
PL376577A1 (pl) | 2002-06-17 | 2006-01-09 | Themis Laboratories Private Limited | Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania |
US6830759B2 (en) | 2002-06-28 | 2004-12-14 | Ajinomoto Co., Inc. | Antidiabetic preparation for oral administration |
US11439815B2 (en) | 2003-03-10 | 2022-09-13 | Impulse Dynamics Nv | Protein activity modification |
US11779768B2 (en) | 2004-03-10 | 2023-10-10 | Impulse Dynamics Nv | Protein activity modification |
US8548583B2 (en) | 2004-03-10 | 2013-10-01 | Impulse Dynamics Nv | Protein activity modification |
WO2007131930A1 (en) * | 2006-05-13 | 2007-11-22 | Novo Nordisk A/S | Tablet formulation comprising repaglinide and metformin |
US20100029721A1 (en) * | 2006-09-29 | 2010-02-04 | Novo Nordisk A/S | Pharmaceutical Formulation Comprising Metformin and Repaglinide |
CN101756971B (zh) * | 2008-10-09 | 2013-09-18 | 北京德众万全药物技术开发有限公司 | 一种盐酸二甲双胍瑞格列奈的口服固体药物组合物 |
WO2011092710A2 (en) | 2010-02-01 | 2011-08-04 | Metacure Limited | Gastrointestinal electrical therapy |
WO2014102715A1 (en) | 2012-12-24 | 2014-07-03 | Ranbaxy Laboratories Limited | Pharmaceutical compositions comprising a biguanide and a low dose antidiabetic agent |
WO2014184742A1 (en) | 2013-05-13 | 2014-11-20 | Ranbaxy Laboratories Limited | Pharmaceutical compositions containing a biguanide and a low dose antidiabetic agent |
WO2018034627A1 (en) | 2016-08-18 | 2018-02-22 | İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi | Pharmaceutical composition of antidiabetic tablet |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2118040A (en) * | 1982-02-15 | 1983-10-26 | Hoechst Uk Ltd | Oral anti-diabetic preparation |
WO1993000337A1 (de) | 1991-06-21 | 1993-01-07 | Dr. Karl Thomae Gmbh | (s)(+)-2-äthoxy-4-[n-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]-benzoesäure |
-
1998
- 1998-06-12 DE DE69800806T patent/DE69800806T2/de not_active Revoked
- 1998-06-12 AT AT98929228T patent/ATE201139T1/de not_active IP Right Cessation
- 1998-06-12 DK DK98929228T patent/DK1011673T3/da active
- 1998-06-12 ZA ZA985126A patent/ZA985126B/xx unknown
- 1998-06-12 EP EP98929228A patent/EP1011673B1/en not_active Revoked
- 1998-06-12 WO PCT/DK1998/000248 patent/WO1998056378A1/en active Search and Examination
- 1998-06-12 EP EP01100320.9A patent/EP1097710B1/en not_active Expired - Lifetime
- 1998-06-12 JP JP50135099A patent/JP2002500677A/ja not_active Withdrawn
- 1998-06-12 ES ES98929228T patent/ES2159184T3/es not_active Expired - Lifetime
- 1998-06-12 PT PT79102124T patent/PT1011673E/pt unknown
- 1998-06-12 AU AU79068/98A patent/AU7906898A/en not_active Abandoned
-
1999
- 1999-12-13 US US09/459,526 patent/US6677358B1/en not_active Expired - Lifetime
-
2000
- 2000-12-28 HK HK00108543A patent/HK1030872A1/xx not_active IP Right Cessation
-
2001
- 2001-06-19 GR GR20010400923T patent/GR3036078T3/el not_active IP Right Cessation
-
2004
- 2004-01-05 JP JP2004000542A patent/JP2004155791A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE69800806D1 (de) | 2001-06-21 |
HK1030872A1 (en) | 2001-05-25 |
AU7906898A (en) | 1998-12-30 |
JP2002500677A (ja) | 2002-01-08 |
EP1097710B1 (en) | 2014-08-20 |
ATE201139T1 (de) | 2001-06-15 |
DK1011673T3 (da) | 2001-07-09 |
GR3036078T3 (en) | 2001-09-28 |
JP2004155791A (ja) | 2004-06-03 |
WO1998056378A1 (en) | 1998-12-17 |
EP1011673B1 (en) | 2001-05-16 |
PT1011673E (pt) | 2001-11-30 |
EP1097710A3 (en) | 2002-05-29 |
EP1011673A1 (en) | 2000-06-28 |
DE69800806T2 (de) | 2001-09-13 |
EP1097710A2 (en) | 2001-05-09 |
US6677358B1 (en) | 2004-01-13 |
ES2159184T3 (es) | 2001-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3036078T3 (en) | Novel niddm regimen | |
KR970004874B1 (en) | Chemically activated shaped carbon, process for producing same and use thereof | |
CA2135575A1 (fr) | Composition cosmetique contenant en tant qu'agent reducteur un n-mercapto-alkyl alcanediamide ou l'un de ses sels cosmetiquement acceptable | |
EP0646354A3 (en) | Autonomous surgical device, activated by a gas cartridge. | |
EP0571442A4 (en) | CYTOKIN INDUCIBLE PROTEIN TSG-14, ITS ENCODING DNA AND THEIR USE. | |
GR3033719T3 (en) | Process for use in flour milling. | |
BG101139A (en) | Heteroatoms-containing cyclopentanopyridyloxazolidinons | |
HU904670D0 (en) | Process for producing 11,15-diacyl-prostaglandines reducing internal pressure in eyeballs and pharmaceutical preparatives containing these compounds | |
EP0641598A3 (en) | Chromium-based fluorination catalyst, process for producing this catalyst and fluorination process using this catalyst. | |
AU567173B2 (en) | Catalyst containing fluorine, chromium and magnesium | |
MY114140A (en) | Novel enzymes and prodrugs for use in antibody-directed enzyme prodrug therapy. | |
AR243412A1 (es) | Un catalizador para la oxidacion de compuestos azufrados presentes en los efluentes gaseosos y el procedimiento de tratamiento de dichos efluentes con dicho catalizador. | |
IL90209A0 (en) | Dna coding for a hiv-1 protein,the protein produced and its use | |
DE58905134D1 (en) | 2,3-difluorbiphenyle. | |
AU3880289A (en) | Bar code printing method and the printer | |
SI0727489T1 (sl) | DNA sekvenca ki kodira protein A thaliane z aktivnostjo delta sterol delta reduktaze protein delta Red postopek za pripravo transformirani sevi kvasovk in uporabe | |
ZA949151B (en) | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents. | |
EP0682169A3 (en) | Pressure actuated device for use in a high pressure well. | |
AU4717089A (en) | N-(3,4-Dioxy-and N-(4-oxy-3-thio-benzyl)-thioureas | |
EP0657438A3 (en) | Process for the preparation of alkylulfinylbenzamides and 1,2-benzoisothiazol-3-ones. | |
EP0612529A3 (en) | Therapeutic agent for NIDDM. | |
MX9700298A (es) | Adenovirus que comprende un gen que codifica para una no sintasa. | |
IT8921505A0 (it) | Regolatore di pressione per gas operante pneumaticamente. | |
ZA93639B (en) | New 4-cinnolinyl- and 4 naphthyridinyl-dihydropyridines, processes for their use in medicaments. | |
DE69019312D1 (de) | Serien-Drucker in Punktmatrixverfahren. |